CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Inclusion Criteria8

• To be eligible to participate in this registry, an individual must meet all the following criteria:
• Has ever been diagnosed with severe AA by a dermatologist or a qualified dermatology provider.
• Is 12-17 years of age at the time of enrollment.
• Is willing to provide consent/assent for participation in the registry.
• Has been prescribed a new commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents in the context of routine clinical care that is consistent with local prescribing guidelines and/or regulations for the country where the site is located.
• A new therapy is a medication that the subject has never taken before.
• At the time of registry enrollment OR
• Within 6 months prior to registry enrollment In the opinion of the treating provider, is deemed a candidate for treatment with a commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents but has not received nor is planning to initiate treatment at the time of registry enrollment.